Previous 10 | Next 10 |
home / stock / rxrx / rxrx articles
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) made waves Monday with the announcement of the completion of its groundbreaking BioHive-2 supercomput...
Shares of Akoustis Technologies, Inc. (NASDAQ:AKTS) fell sharply in today's session following weak quarterly results. Akoustis Technologies po...
U.S. stocks were higher, with the Dow Jones gaining more than 90 points on Monday. Shares of GameStop Corp. (NYSE:GME) rose sharply during Monday...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended selling Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR)...
On Thursday, Cathie Wood’s Ark Invest made significant trades involving Coinbase Global, Inc. (NASDAQ:COIN), Palantir Technologies Inc. (NYSE...
On Tuesday, Cathie Wood’s Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccin...
Last week, Nvidia Corp (NASDAQ:NVDA) announced significant collaborations with Johnson & Johnson (NYSE:JNJ) and General Ele...
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-exp...
Nvidia Corp. (NASDAQ:NVDA), the posterchild of the AI revolution, did not just capitalize on the rising demand for its AI accelerators but has also...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...